SLVM Stock Analysis: Sylvamo | NYSE
Paper & Paper Products | NYSE, USA | Market Cap: 1.430m USD | 12M Return: -23.4% | US8713321029 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 10.9M
EPS Trend: -79.9%
Qual. Beats: 0
Rev. Trend: -86.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sylvamo Corporation is a global producer of uncoated freesheet paper, operating in Europe, Latin America, and North America. The company manufactures copy, tinted, and colored laser printing paper under the REY brand, graphic and inkjet papers under the Berga brand, and office and digital printing papers under the Multicopy brand. It also sells uncoated freesheet under brands including Chamex, Chamequinho, Chambril, Hammermill, Springhill, Williamsburg, Accent, DRM, and Postmark. Sylvamo operates both integrated mills (which produce pulp from wood fiber) and non-integrated mills (which purchase market pulp), and distributes its products through retail, merchant, and e-commerce channels to converters, agents, resellers, and paper distributors.
The company was founded in 1898 and is headquartered in Memphis, Tennessee. Sylvamo was spun off from International Paper in October 2021 as an independent, publicly traded entity focused exclusively on uncoated freesheet paper, a commodity segment of the broader paper products industry that has faced long-term demand pressure from digital substitution in office and print applications.
- European pulp and uncoated freesheet prices rebound on demand recovery
- Latin America copy paper demand supports Chamex brand revenue growth
- North American office printing volumes decline as remote work persists
| Net Income: 76.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -3.75 > 1.0 |
| NWC/Revenue: 10.77% < 20% (prev 9.63%; Δ 1.13% < -1%) |
| CFO/TA 0.07 > 3% & CFO 209.0m > Net Income 76.0m |
| Net Debt (841.0m) to EBITDA (363.0m): 2.32 < 3 |
| Current Ratio: 1.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.8m) vs 12m ago -3.16% < -2% |
| Gross Margin: 20.38% > 18% (prev 20.56%; Δ -0.18% > 0.5%) |
| Asset Turnover: 119.0% > 50% (prev 133.1%; Δ -14.10% > 0%) |
| Interest Coverage Ratio: 4.40 > 6 (EBIT TTM 185.0m / Interest Expense TTM 42.0m) |
| A: 0.12 (Total Current Assets 1.11b - Total Current Liabilities 752.0m) / Total Assets 2.88b |
| B: 0.86 (Retained Earnings 2.46b / Total Assets 2.88b) |
| C: 0.07 (EBIT TTM 185.0m / Avg Total Assets 2.77b) |
| D: 0.50 (Book Value of Equity 955.0m / Total Liabilities 1.92b) |
| Altman-Z'' = 4.57 = AA |
| DSRI: 0.98 (Receivables 366.0m/404.0m, Revenue 3.30b/3.55b) |
| GMI: 1.01 (GM 20.56% / 20.38%) |
| AQI: 0.92 (AQ_t 0.21 / AQ_t-1 0.22) |
| SGI: 0.93 (Revenue 3.30b / 3.55b) |
| TATA: -0.05 (NI 76.0m - CFO 209.0m) / TA 2.88b) |
| Beneish M = -3.14 (Cap -4..+1) = AA |
As of October 03, 2026, the stock is trading at USD 32.48 with a total of 361,616 shares traded. Over the past week, the price has changed by -8.44%, over one month by -8.05%, over three months by -13.57% and over the past year by -23.36%.
Current recommended Stop Loss: 30.90 (which is 4.9% or 1.3 ATR below the current price).
Sylvamo has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold SLVM.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 50.4 | 55.2% |
P/E Trailing = 19.2299
P/E Forward = 7.0922
P/S = 0.4337
P/B = 1.5255
Revenue TTM = 3.30b USD
EBIT TTM = 185.0m USD
EBITDA TTM = 363.0m USD
Long Term Debt = 843.0m USD (from longTermDebt, last quarter)
Short Term Debt = 121.0m USD (from shortTermDebt, last quarter)
Debt = 964.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 841.0m USD (calculated: Debt 964.0m - CCE 123.0m)
Enterprise Value = 2.27b USD (1.43b + Debt 964.0m - CCE 123.0m)
Interest Coverage Ratio = 4.40 (Ebit TTM 185.0m / Interest Expense TTM 42.0m)
EV/FCF = 22.94x (Enterprise Value 2.27b / FCF TTM 99.0m)
FCF Yield = 4.36% (FCF TTM 99.0m / Enterprise Value 2.27b)
FCF Margin = 3.00% (FCF TTM 99.0m / Revenue TTM 3.30b)
Net Margin = 2.31% (Net Income TTM 76.0m / Revenue TTM 3.30b)
Gross Margin = 20.38% ((Revenue TTM 3.30b - Cost of Revenue TTM 2.62b) / Revenue TTM)
Gross Margin QoQ = 16.38% (prev 11.13%)
Tobins Q-Ratio = 0.79 (Enterprise Value 2.27b / Total Assets 2.88b)
Interest Expense / Debt = 4.36% (Interest Expense 42.0m / Debt 964.0m)
Taxrate = 46.10% (65.0m / 141.0m)
NOPAT = 99.7m (EBIT 185.0m * (1 - 46.10%))
Current Ratio = 1.47 (Total Current Assets 1.11b / Total Current Liabilities 752.0m)
Debt / Equity = 1.01 (Debt 964.0m / totalStockholderEquity, last quarter 955.0m)
Debt / EBITDA = 2.32 (Net Debt 841.0m / EBITDA 363.0m)
Debt / FCF = 8.49 (Net Debt 841.0m / FCF TTM 99.0m)
Total Stockholder Equity = 969.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.74% (Net Income 76.0m / Total Assets 2.88b)
RoE = 7.84% (Net Income TTM 76.0m / Total Stockholder Equity 969.2m)
RoCE = 10.21% (EBIT 185.0m / Capital Employed (Equity 969.2m + L.T.Debt 843.0m))
RoIC = 4.70% (NOPAT 99.7m / Invested Capital 2.12b)
WACC = 5.79% (E(1.43b)/V(2.39b) * Re(8.11%) + D(964.0m)/V(2.39b) * Rd(4.36%) * (1-Tc(0.46)))
Discount Rate = 8.11% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.63 | Cagr: -2.47%
[DCF] Terminal Value 73.10% ; FCFF base≈136.2m ; Y1≈119.4m ; Y5≈96.5m
[DCF] Fair Price = 17.81 (EV 1.55b - Net Debt 841.0m = Equity 708.0m / Shares 39.8m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -79.89 | EPS CAGR: -32.23% | SUE: 0.81 | # QB: 0
Revenue Correlation: -86.62 | Revenue CAGR: -5.02% | SUE: -0.29 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.28 | Chg30d=+5.84% | Revisions=-50% | Analysts=5
EPS current Year (2026-12-31): EPS=1.53 | Chg30d=+5.15% | Revisions=-50% | GrowthEPS=-56.8% | GrowthRev=-1.2%
EPS next Year (2027-12-31): EPS=5.20 | Chg30d=+2.30% | Revisions=-40% | GrowthEPS=+239.9% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: -73% (up=0, down=8)